- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01172899
Bariatric Surgery in Children. (BASIC)
The BASIC Trial. Morbid Obesity in Children and Adolescents: a Prospective Randomised Trial of Conservative Treatment Versus Surgery
Rationale:
In the Western world overweight and obesity is an increasing problem both in adults and in children. In youth, it is associated with early death and a number of co-morbidities including metabolic and endocrine changes, increased inflammatory status, cardiovascular abnormalities, nonalcoholic fatty liver disease, and impaired quality of life.
The standard treatment for morbid obesity in children is by combined life style interventions. However, the medium and long term effects of dietetic interventions, behaviour therapy and medication is relatively poor. In adults bariatric surgery shows good results with up to 30% weight reduction in 3 years. The preliminary results in youth are similar, but surgery in this age group is relatively uncommon. In the Netherlands surgery in this age group is only allowed in clinical trials, until the benefits and risks have been established. (National Health Authorities)
Objective:
To determine if surgery gives a superior weight and body mass index (BMI) reduction than combined life style interventions in adolescents with morbid obesity and to assess its effect on obesity associated co-morbidity.
Study design:
Prospective randomised interventional study.
Study population:
Morbidly obese children, aged 14 - 16 years, with sex and age adjusted BMI >40 kg/m2 or >35 kg/m2 with co-morbidity.
Intervention:
Bariatric surgery by laparoscopic adjustable gastric band (LAGB) or combined life style interventions
Main study parameters/endpoints:
Primary endpoints: weight loss, loss of excess weight, loss of excess BMI. Secondary endpoints: Body composition, pubertal development, metabolic and endocrine changes, inflammatory status, cardiovascular abnormalities, non-alcoholic steatohepatitis, brain development, quality of life, and behaviour changes. The potential complications of surgery are monitored.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Limburg
-
Maastricht, Limburg, Nederländerna, 6202ZA
- Maastricht University Medical Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Aged 14 to 16
Age and sex adjusted BMI >40 kg/m2 or >35 kg/m2 with associated co-morbidity.
* Associated co-morbidity includes: glucose intolerance, type 2 diabetes, hypertension, pseudotumor cerebri, acanthosis nigricans, obstructive sleep apnoea syndrome, depression, arthropathies, non-alcoholic steatohepatitis and dyslipidemia.
- > 1 year multidisciplinary organized weight reducing attempts with less than 5% weight loss
- Demonstrate decisional capacity
Exclusion Criteria:
- Psychologically not suitable
- Pre-menarche or bone age <15 years in boys
- Obesity associated to other disorders such as hypothyroidism
- Syndromal disorders such as Prader-Willi syndrome
- Severe cardiorespiratory impairment (ASA class 3 or higher)
- Insufficiently fluid in the Dutch language
- Unwillingness to adhere to follow-up programmes
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Kontrollgrupp
|
Control group will receive standard therapy consisting of combined lifestyle interventions.
|
|
Experimentell: Laparoscopic adjustable gastric band
|
Laparoscopic gastric band placement.
Combined lifestyle interventions will continue after surgery.
Control group will receive standard therapy consisting of combined lifestyle interventions.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Weight
Tidsram: 6 months
|
Weight loss, excess weight loss and loss of excess BMI.
|
6 months
|
|
Weight
Tidsram: 12 months
|
Weight loss, excess weight loss and loss of excess BMI.
|
12 months
|
|
Weight
Tidsram: 24 months
|
Weight loss, excess weight loss and loss of excess BMI.
|
24 months
|
|
Weight
Tidsram: 36 months
|
Weight loss, excess weight loss and loss of excess BMI.
|
36 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Body composition
Tidsram: 12 months
|
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
|
12 months
|
|
Pubertal development
Tidsram: 6 months
|
Follow-up of hormonal status and Tanner stages.
|
6 months
|
|
Metabolic and endocrine changes
Tidsram: 6 months
|
6 months
|
|
|
Inflammatory status
Tidsram: 6 months
|
Measurement of serum inflammatory markers.
|
6 months
|
|
Cardiovascular abnormalities
Tidsram: 6 months
|
6 months
|
|
|
Non-alcoholic fatty liver disease
Tidsram: 6 months
|
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured.
CCL-2 is used as a surrogate marker to assess liver disease.
|
6 months
|
|
Quality of life changes
Tidsram: 6 months
|
6 months
|
|
|
Behaviour changes
Tidsram: 6 months
|
Measuring impulsivity and positive reward dominance with a computer task.
|
6 months
|
|
Operative complications
Tidsram: up to 36 months
|
Early and late complications are being monitored
|
up to 36 months
|
|
Effects on sleep architecture
Tidsram: 6 months
|
6 months
|
|
|
Brain development
Tidsram: 6 months
|
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
|
6 months
|
|
Body composition
Tidsram: 24 months
|
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
|
24 months
|
|
Body composition
Tidsram: 36 months
|
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
|
36 months
|
|
Pubertal development
Tidsram: 12 months
|
Follow-up of hormonal status and Tanner stages.
|
12 months
|
|
Pubertal development
Tidsram: 24 months
|
Follow-up of hormonal status and Tanner stages.
|
24 months
|
|
Pubertal development
Tidsram: 36 months
|
Follow-up of hormonal status and Tanner stages.
|
36 months
|
|
Metabolic and endocrine changes
Tidsram: 12 months
|
12 months
|
|
|
Metabolic and endocrine changes
Tidsram: 24 months
|
24 months
|
|
|
Metabolic and endocrine changes
Tidsram: 36 months
|
36 months
|
|
|
Inflammatory status
Tidsram: 12 months
|
Measurement of serum inflammatory markers.
|
12 months
|
|
Inflammatory status
Tidsram: 24 months
|
Measurement of serum inflammatory markers.
|
24 months
|
|
Inflammatory status
Tidsram: 36 months
|
Measurement of serum inflammatory markers.
|
36 months
|
|
Cardiovascular abnormalities
Tidsram: 12 months
|
12 months
|
|
|
Cardiovascular abnormalities
Tidsram: 24 months
|
24 months
|
|
|
Cardiovascular abnormalities
Tidsram: 36 months
|
36 months
|
|
|
Non-alcoholic fatty liver disease
Tidsram: 12 months
|
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured.
CCL-2 is used as a surrogate marker to assess liver disease.
|
12 months
|
|
Non-alcoholic fatty liver disease
Tidsram: 24 months
|
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured.
CCL-2 is used as a surrogate marker to assess liver disease.
|
24 months
|
|
Non-alcoholic fatty liver disease
Tidsram: 36 months
|
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured.
CCL-2 is used as a surrogate marker to assess liver disease.
|
36 months
|
|
Quality of life changes
Tidsram: 12 months
|
12 months
|
|
|
Quality of life changes
Tidsram: 24 months
|
24 months
|
|
|
Quality of life changes
Tidsram: 36 months
|
36 months
|
|
|
Effects on sleep architecture
Tidsram: 12 months
|
12 months
|
|
|
Effects on sleep architecture
Tidsram: 24 months
|
24 months
|
|
|
Effects on sleep architecture
Tidsram: 36 months
|
36 months
|
|
|
Behaviour changes
Tidsram: 12 months
|
Measuring impulsivity and positive reward dominance with a computer task.
|
12 months
|
|
Behaviour changes
Tidsram: 24 months
|
Measuring impulsivity and positive reward dominance with a computer task.
|
24 months
|
|
Behaviour changes
Tidsram: 36 months
|
Measuring impulsivity and positive reward dominance with a computer task.
|
36 months
|
|
Brain development
Tidsram: 12 months
|
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
|
12 months
|
|
Brain development
Tidsram: 24 months
|
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
|
24 months
|
|
Brain development
Tidsram: 36 months
|
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
|
36 months
|
|
Physical activity
Tidsram: 6 months
|
Assessment of physical activity using a questionnaire and an accelerometer.
|
6 months
|
|
Physical activity
Tidsram: 12 months
|
Assessment of physical activity using a questionnaire and an accelerometer.
|
12 months
|
|
Physical activity
Tidsram: 24
|
Assessment of physical activity using a questionnaire and an accelerometer.
|
24
|
|
Physical activity
Tidsram: 36 months
|
Assessment of physical activity using a questionnaire and an accelerometer.
|
36 months
|
|
Behavior towards food
Tidsram: 6 months
|
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
|
6 months
|
|
Behavior towards food
Tidsram: 12 months
|
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
|
12 months
|
|
Behavior towards food
Tidsram: 24 months
|
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
|
24 months
|
|
Behavior towards food
Tidsram: 36 months
|
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
|
36 months
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: LWE van Heurn, Professor, Maastricht University Medical Center
- Huvudutredare: Yvonne Roebroek, PhD Student, Maastricht University Medical Center
- Huvudutredare: Givan F Paulus, PhD Student, Spaarne Gasthuis, Haarlem
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- NL26279.068.09
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .